Protein Summary
Plays a key role in glycolysis. The protein encoded by this gene is a pyruvate kinase that catalyzes the transphosphorylation of phohsphoenolpyruvate into pyruvate and ATP, which is the rate-limiting step of glycolysis. Defects in this enzyme, due to gene mutations or genetic variations, are the common cause of chronic hereditary nonspherocytic hemolytic anemia (CNSHA or HNSHA). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
- ENST00000342741
- ENSP00000339933
- ENSG00000143627
- ENST00000392414
- ENSP00000376214
- ENST00000571194
- ENSP00000461487
- ENSG00000262785
- ENST00000572740
- ENSP00000459921
- PK1
- PKL
- PK1
- PKL
- RPK
- PKRL
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
protein domain | 0.97 | ||
molecular function | 0.95 | ||
biological process | 0.94 | ||
disease perturbation | 0.79 | ||
disease | 0.73 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 424.45 (req: < 5)
Gene RIFs: 72 (req: <= 3)
Antibodies: 487 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 424.45 (req: >= 5)
Gene RIFs: 72 (req: > 3)
Antibodies: 487 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 15
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 1